| Literature DB >> 12648453 |
Ing Swie Goping1, Michele Barry, Peter Liston, Tracy Sawchuk, Gabriela Constantinescu, Karolina M Michalak, Irene Shostak, Darren L Roberts, Allison M Hunter, Robert Korneluk, R Chris Bleackley.
Abstract
Cytotoxic lymphocytes employ Granzyme B as a potent initiator of apoptosis to cleave and activate effector caspases. Unexpectedly, cells transfected with Bcl-2 were resistant to granzyme B-induced killing, suggesting that a mitochondrial pathway was critical. Utilizing cells expressing a dominant-negative caspase 9, the current study demonstrated that caspase activation via the apoptosome was not required. Indeed, cleavage of caspase 3 to p20 still occurred in Bcl-2-transfectants but processing to p17 was blocked. This blockade was recapitulated by the Inhibitor-of-Apoptosis-Protein XIAP and relieved by Smac/DIABLO. Thus granzyme B mediates direct cleavage of caspase 3 and also activates mitochondrial disruption, resulting in the release of proapoptotic proteins that suppress caspase inhibition. Engagement of both pathways is critical for granzyme-induced killing.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12648453 DOI: 10.1016/s1074-7613(03)00032-3
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745